The Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that COVID-19 vaccination should no longer be a universal requirement for everyone over the age of six months, but rather an individualized decision. According to the committee, the new guidance applies to both children and adults, but it emphasizes that the benefits of vaccination are more evident in individuals at higher risk of severe illness, while in those without such conditions, the impact is less significant.
The change is framed within the concept of “shared clinical decision-making,” which means that patients, together with their physicians, nurses, or pharmacists, will decide whether vaccination is the most appropriate option in each case. The recommendation does not mean that vaccines will require a prescription or that access will be restricted. On the contrary, health authorities confirmed that health insurers will continue to cover the costs of the doses through federal programs such as Medicaid, Medicare, and the Vaccines for Children program.
The objective is to ensure that all citizens who wish to protect themselves will continue to have access to immunization without financial barriers. This change is part of a broader review of immunization policy promoted by Health Secretary Robert F. Kennedy Jr., who has emphasized the need for greater transparency in public health processes and a more personalized approach.
Health experts warn that the new directive could create confusion among the population, particularly in rural communities or areas with limited access to medical services, and therefore stress the need to strengthen information campaigns about risks, benefits, and eligibility criteria. They particularly underline that individuals over 65, immunocompromised patients, and other vulnerable groups remain a priority for vaccination.
Insurers have indicated that they will maintain coverage of vaccines under the previous recommendations until at least the end of 2026, providing a margin of stability for the transition. With this resolution, ACIP marks a turning point in U.S. COVID-19 vaccination policy, moving toward a more flexible model centered on the informed responsibility of each individual, which could redefine health campaigns and the relationship between government, health professionals, and citizens in the coming months.
